WELLBEING PHARMACIES LIMITEDActive

Company number SC332091Private limited companyIncorporated 2007

Key figures

£182,613-21.8%
Net assets 2025
-6.2%
Average annual change 2020–2025
0100 k200 k300 k400 k202020212022202320242025

Like most small UK companies, WELLBEING PHARMACIES LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m3 m202020212022202320242025
Filed accounts2020–2025
20212022202320242025
Profit for the year———159,086—
Cash at bank and in hand211,129115,408220,538193,663187,495
Total assets1,032,1761,029,3852,119,3211,811,6781,702,175
Total liabilities646,699663,5821,762,5621,556,0181,491,917
Net assets / total equity385,477365,803356,759233,495182,613
Average number of employees1820253532

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: WELLBEING PHARMACIES LIMITED

Company

WELLBEING PHARMACIES LIMITED is a private limited company registered with Companies House under company number SC332091. It was incorporated on 9 Oct 2007. Its status is active. The registered office is in Kirkcaldy (KY1). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Net assets were £182,613, down 21.8% on the previous year. Cash at bank and in hand was £187,495. Total assets were £1,702,175 and total liabilities £1,491,917. The company had an average of 32 employees. Figures are available for 6 financial years (2020–2025).

Control and charges

One person with significant control is registered. 2 of 6 registered charges are outstanding.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 23 Nov 2026.